Drug Shortage Report for SANDOZ-CARBAMAZEPINE CR

Last updated on 2025-03-12 History
Report ID 225212
Drug Identification Number 02261847
Brand name SANDOZ-CARBAMAZEPINE CR
Common or Proper name CARBAMAZEPINE CR
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 400MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100MRT
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-04-15
Estimated end date 2024-08-30
Actual end date 2024-07-02
Shortage status Resolved
Updated date 2025-03-12
Company comments Product available under allocation.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v28 2025-03-12 English Compare
v27 2024-07-03 English Compare
v26 2024-07-02 French Compare
v25 2024-07-02 English Compare
v24 2024-06-25 French Compare
v23 2024-06-25 English Compare
v22 2024-06-25 French Compare
v21 2024-06-25 English Compare
v20 2024-06-25 French Compare
v19 2024-06-25 English Compare
v18 2024-06-25 English Compare
v17 2024-06-25 French Compare
v16 2024-06-25 French Compare
v15 2024-06-25 English Compare
v14 2024-06-25 French Compare
v13 2024-06-25 English Compare
v12 2024-06-18 French Compare
v11 2024-06-18 English Compare
v10 2024-06-17 French Compare
v9 2024-06-17 English Compare

Showing 1 to 20 of 28